Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 13, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The RETRO-LYMPH study is a research project that looks back at the medical histories of patients in Italy who have been diagnosed with lymphoma or a related condition called lymphoproliferative syndrome between January 1980 and September 2021. This study is observational, meaning it does not involve any experimental treatments; instead, researchers are gathering information to better understand how these conditions have affected patients over time. The study aims to recruit individuals aged 18 and older who have had these diagnoses during the specified time frame.
If you or a loved one has been diagnosed with lymphoma or lymphoproliferative syndrome, you may be eligible to participate in this study. There are no specific exclusions based on health conditions, but participants must be able to provide informed consent. By participating, you will help researchers gain important insights that could improve future treatments and care for individuals with these conditions. If you are interested, you can reach out to the study team for more information on how to get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 18 years of enrollment
- • Diagnosis of lymphoma or lymphoproliferative syndrome between January 1980 and September 2021
- • Signature of the informed consent form where applicable
- Exclusion Criteria:
- • none
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Pier Luigi Zinzani, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported